[Starkus]

Ah, reminds me of investing (poorly) in Amplify Biosciences in late 2017...

Since acquired by Armata pharma, which trades around 4 a share, cap of 40M.... I lost 90% of my investment, oh darn, was a bad investment in hindsight.

Looking at that chart in the article, not too surprised the rest of the market in big red territory.